首页> 外文期刊>Frontiers in Cardiovascular Medicine >Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy
【24h】

Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy

机译:巴尔干地方性肾病的动脉僵硬度,马兜铃酸肾病的一种环境形式

获取原文
       

摘要

Balkan endemic nephropathy (BEN), an environmental form of aristolochic acid nephropathy is characterized with later onset and milder forms of hypertension (HT). Thus, we hypothesized that arterial stiffness progresses slower in BEN patients resulting in lower CV mortality. A total of 186 hemodialysed (HD) patients (90 BEN, 96 non-BEN; 67.3 + 13.0 years) were enrolled and followed-up for 25 months. Brachial blood pressure (BP) and pulse wave velocity (PWV) were determined before mid-week dialysis. BEN patients were older (72.1 ± 37.1 vs. 62.8 ± 15.1; p < 0.001), had shorter duration of HT prior commencement of HD than non-BEN patients (36 vs. 84 months; p < 0.001). There were no differences in BP, but BEN patients were treated with less antihypertensive drugs (p < 0.01). BEN patients had lower PWV values at baseline and at the end of follow-up period despite being chronologically older (p < 0.001). Baseline PWV > 10 m/s was associated with higher risk for CV mortality (aHR 1.8 [1.4, 2.4]). In multivariate analyses BEN was predictor of lower PWV. During the follow-up period significantly less CV deaths were observed in BEN vs. on-BEN patients (12 vs. 31; p = 0.001). CV mortality adjusted for other risk factors was significantly lower in BEN group (aHR 0.2 [0.1, 0.5]). Overall BEN patients had longer mean survival time on HD (22.3 vs. 18.2 months; p < 0.001). Observed slower vascular aging (i.e., lower PWV) in BEN patients compared to other ESRD patients is related to the later onset of HT and milder stages of HT during predialytic clinical course and better control of BP and phosphate during HD.
机译:巴尔干地方性肾病(BEN)是马兜铃酸肾病的一种环境形式,其特征是高血压(HT)的发作较晚且较轻。因此,我们假设BEN患者的动脉僵硬进展较慢,导致CV死亡率降低。共有186名血液透析(HD)患者(90名BEN,96名非BEN; 67.3 + 13.0岁)入组并随访25个月。在周中透析前测定肱动脉血压(BP)和脉搏波速度(PWV)。 BEN患者年龄较大(72.1±37.1 vs. 62.8±15.1; p <0.001),HD开始之前的HT持续时间比非BEN患者短(36 vs. 84个月; p <0.001)。血压无差异,但BEN患者使用的降压药较少(p <0.01)。 BEN患者在基线时和随访期末PWV值较低,尽管年代久远(p <0.001)。基线PWV> 10 m / s与CV死亡率较高相关(aHR 1.8 [1.4,2.4])。在多变量分析中,BEN是较低PWV的预测因子。在随访期间,BEN患者与BEN患者相比,CV死亡显着减少(12 vs. 31; p = 0.001)。 BEN组中经其他危险因素调整后的CV死亡率显着降低(aHR 0.2 [0.1,0.5])。总体上,BEN患者的HD平均生存时间更长(22.3 vs. 18.2个月; p <0.001)。与其他ESRD患者相比,BEN患者观察到的血管衰老较慢(即PWV较低)与在透析前临床过程中HT的发作较晚和HT的温和阶段以及HD期间对BP和磷酸盐的更好控制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号